Literature DB >> 8300889

Clinical cardiotoxicity of 5-fluorouracil.

D L Keefe1, N Roistacher, M K Pierri.   

Abstract

5-Fluorouracil is widely known to be toxic to the hematopoietic and gastrointestinal systems. It also has cardiac toxicity, but this is perceived to be rare. During a 16-month period from January 1990 through April 1991, approximately 910 patients were treated with 5-fluorouracil. Five of these developed life-threatening toxicity consistent with coronary artery spasm for an incidence of .55%. The acute events occurred on the third or fourth day of the 5-day infusion and after the fourth intravenous bolus in the patient on bolus therapy. Each of the patients had ST elevation and ventricular arrhythmias, four had acute myocardial infarction, and two had cardiac arrests. In these cases and those previously reported, cardiac toxicity is consistent with drug- or metabolite-mediated increases in coronary vasomotor tone and spasm, leading to the full spectrum of signs and symptoms of myocardial ischemia in susceptible individuals.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8300889     DOI: 10.1002/j.1552-4604.1993.tb01943.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  18 in total

1.  [Angina pectoris and ST-elevation after chemotherapy with 5-fluorouracil].

Authors:  S Spencker; A Schmittel; D Westermann; A Marek; H P Schultheiss; B Witzenbichler
Journal:  Internist (Berl)       Date:  2007-01       Impact factor: 0.743

2.  Severe 5-fluorouracil toxicity caused by reduced dihydropyrimidine dehydrogenase activity due to heterozygosity for a G-->A point mutation.

Authors:  A B van Kuilenburg; P Vreken; L V Beex; R A De Abreu; A H van Gennip
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

Review 3.  Cancer chemotherapy and cardiac arrhythmias: a review.

Authors:  Juan Tamargo; Ricardo Caballero; Eva Delpón
Journal:  Drug Saf       Date:  2015-02       Impact factor: 5.606

Review 4.  Pharmacogenomics in Cytotoxic Chemotherapy of Cancer.

Authors:  Zahra Talebi; Alex Sparreboom; Susan I Colace
Journal:  Methods Mol Biol       Date:  2022

5.  Acute ischaemic cerebrovascular attack secondary to infusional 5-fluoruracil and cisplatin in a patient with advanced gastric cancer.

Authors:  I Garrido-Laguna; M L Amador; J Ruiz; H Cortés-Funes
Journal:  Clin Transl Oncol       Date:  2009-03       Impact factor: 3.405

Review 6.  Electrophysiologic Toxicity of Chemoradiation.

Authors:  Merna A Armanious; Shreya Mishra; Michael G Fradley
Journal:  Curr Oncol Rep       Date:  2018-04-11       Impact factor: 5.075

7.  Takotsubo cardiomyopathy caused by infusion reaction to trastuzumab.

Authors:  Toshihiko Matsumoto; Takashi Oda; Yu Yoshida; Shogo Kimura; Hitomi Himei; Takao Tsuduki; Shinjiro Takagi; Masahiro Takatani; Hirofumi Morishita
Journal:  Int Cancer Conf J       Date:  2019-12-06

Review 8.  Management of ischemic coronary disease in patients receiving chemotherapy: an uncharted clinical challenge.

Authors:  Bibhu D Mohanty; Sudipta Mohanty; Yasin Hussain; Chandrasekhar Padmaraju; Sameer Aggarwal; Rebekah Gospin; Anthony F Yu
Journal:  Future Cardiol       Date:  2017-06-01

9.  Critical limb ischaemia associated with chemotherapy for breast cancer.

Authors:  W V Garrett; J R I Brown; D Pickering; S M Andrews
Journal:  J R Soc Med       Date:  2004-09       Impact factor: 18.000

10.  Long-term health outcomes in a British cohort of breast, colorectal and prostate cancer survivors: a database study.

Authors:  N F Khan; D Mant; L Carpenter; D Forman; P W Rose
Journal:  Br J Cancer       Date:  2011-11-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.